It is evident from the figure that the majority of ERG-high cancers displayed decreased expression of EPB41L3 and increased expression of EPB41L4B, whereas most of the ERG-low carcinomas had expression levels of the two genes within the range of benign tissues. This evidence concerns the gene EPB41L4B and carcinoma.